Athersys

$1.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-6.81%) Today
+$0.03 (+1.69%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Athersys and other stocks, options, and ETFs commission-free!

About ATHX

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas.

CEO
William B. J. Lehmann
Employees
97
Headquarters
Cleveland, Ohio
Founded
1995
Market Cap
371.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.56M
High Today
$1.90
Low Today
$1.77
Open Price
$1.90
Volume
1.66M
52 Week High
$3.59
52 Week Low
$1.53

ATHX Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

SMAR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure